Navigation Links
Alpha-1 Foundation President to Give Keynote Address at 53rd Annual Respiratory Congress of the AARC Foundation and Activities

MIAMI, Oct. 25 /PRNewswire/ -- John W. Walsh, president of the COPD Foundation, will give the keynote address at the 53rd International Respiratory Congress of the American Association for Respiratory Care (AARC) Dec. 1 in Orlando, FL. AARC is a 43,000-member association representing respiratory therapists involved in the treatment and care of individuals of all ages who suffer a range of respiratory illness, including asthma, cystic fibrosis, and Chronic Obstructive Pulmonary Disease (COPD), the fourth largest cause of death in the United States.

Walsh and the COPD Foundation have been involved as key partners with the AARC and other organizations in the NIH, National Heart, Lung & Blood Institute (NHLBI) "Learn More, Breathe Better" campaign, the first-ever national COPD awareness and education campaign.

As part of that NHLBI campaign, the COPD Foundation and AARC send Mobile Spirometry Units (MSU) all over the United States, to health fairs, fitness expositions and other events, offering free spirometry to encourage early diagnosis of those at risk for COPD and to inform them about Alpha-1 Antitrypsin Deficiency. The AARC has collaborated and ensures that respiratory therapists meet the MSU at each location to perform spirometries and answer questions.

Walsh recently lobbied Congress with Grace Anne Dorney Koppel, a patient advocate for the "Learn More, Breathe Better" campaign, and AARC Executive Director Sam Giordano, urging that pulmonary rehabilitation be established as a Medicare benefit.

Well-known as an inspirational and motivational patient speaker, Walsh has COPD related to Alpha-1 Antitrypsin Deficiency, the most common known genetic risk factor for COPD. Diagnosed with Alpha-1 in 1989, he is also the co- founder, President and CEO of the Alpha-1 Foundation in Miami, FL. He regularly testifies before Congress and advisory groups as a patient advocate.

In 2002, he was recognized by the FDA with the Commissioner's Special Citation for his work in pioneering collaborations in orphan drug development. He is the Chair of the International COPD Coalition and a member of the US COPD Coalition Executive Committee; Immediate Past Chair and member of the American Thoracic Society's Public Advisory Roundtable; 2005-2006 Chair of the National Health Council's Board of Directors; a member of the American Lung Association's National Action Panel on Lung Disease; and was the 2004-2005 Presidential Appointee of the American Thoracic Society's Board of Directors.

Some 3,000 respiratory therapists are expected to attend the 53rd International Congress in Orlando.

About the COPD Foundation:

The COPD Foundation is dedicated to developing and supporting programs which improve the quality of life through research, education, early diagnosis, and enhanced therapy for persons whose lives are impacted by Chronic Obstructive Pulmonary Disease.

For more information, please visit

About the Alpha-1 Foundation: The mission of the Alpha-1 Foundation is to provide the leadership and resources that will result in increased research, improved health, worldwide detection, and a cure for Alpha-1 Antitrypsin Deficiency. For more information, please visit: Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Mark Brantly Charlie Strange Holly Miller Michael Campos Adam Wanner Robert Sandhaus John Walsh

SOURCE Alpha-1 Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Woodruff Foundation Grant To Support Doctorate Of Nursing Practice Program
2. Kalam To Lay Foundation Of Vellore Research Center
3. Nippon Foundation To Help Leprosy Patients
4. Parents Launch SV40 Cancer Foundation In Memory of Son
5. Cancer Aid And Research Foundation: Offering Endless Hope To Cancer Patients
6. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
7. PM Launches Healthcare Foundation For India
8. Prime Minister Manmohan Singh, Flags Off Public Health Foundation of India
9. Gates Foundation to donate USD 104 million to TB Alliance
10. MoU for HIV/AIDS Signed by Nigeria and Clinton Foundation
11. Gates Foundation Adopts Fight against Encephalitis
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about ... intend to develop to enable prevention of a major side effect of chemotherapy ... especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... On ... holding a treadmill relay – Miles by Moonlight to raise money for the American ... $300 or more. , Teams will work together to keep their treadmills moving ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief Medical Officer ... physician colleagues, skilled nursing facility medical directors and other clinicians at various events ... Care." , "At many of these conferences we get to educate other physicians, ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- Halo Labs announces the European launch of their new low ... MIBio 2017 in Cambridge, U.K on October ... biopharmaceutical samples with unprecedented speed and sensitivity while using far less ... Imaging. ... analysis system ...
(Date:9/27/2017)... -- Commended for their devotion to personalized service, SMP Pharmacy Solutions ... in the South Florida Business Journal,s 50 Fastest-Growing Companies, and ... the national specialty pharmacy has found its niche.  To that ... be honored by SFBJ as the 2017 Power Leader in ... receive his award in October, Bardisa said of the three ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology: